AAV2-GDNF gene therapy

BIOLOGICAL2 trials

Sponsors

Brain Neurotherapy Bio, Inc., AskBio Inc

Conditions

Multiple System AtrophyParkinson Disease

Phase 1

GDNF Gene Therapy for Multiple System Atrophy

Active, not recruitingNCT04680065

Brain Neurotherapy Bio, Inc.Multiple System Atrophy

Start: 2023-10-03End: 2028-08-01Target: 9Updated: 2026-01-30

Phase 2

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

RecruitingNCT06285643

AskBio IncParkinson Disease

Start: 2024-06-11End: 2028-08-31Target: 127Updated: 2026-06-29